Total planned funding: $12,103,674
Allocations
Countries/Regions
Central Asia Region | $12,103,674 |
Organizational Types
Own Agency | $12,103,674 |
Program Areas
Management and Operations | $7,080,120 |
Prevention | $1,979,922 |
Governance and Systems | $1,433,155 |
Care | $619,516 |
Testing | $582,690 |
Treatment | $408,271 |
Budget Codes
HVMS: Management and Operations | $7,080,120 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,432,398 |
HVCT: Testing: HIV Testing and Counseling | $582,690 |
HBHC: Care: Adult Care and Support | $537,185 |
HVSI: Strategic Information | $528,876 |
HLAB: Laboratory Infrastructure | $515,577 |
HTXS: Treatment: Adult Treatment | $390,102 |
OHSS: Health Systems Strengthening | $388,702 |
HVOP: Sexual Prevention: Other Sexual Prevention | $366,041 |
HMBL: Biomedical Prevention: Blood Safety | $131,194 |
HVTB: Care: TB/HIV | $82,331 |
HMIN: Biomedical Prevention: Injection Safety | $50,289 |
HTXD: Treatment: ARV Drugs | $18,169 |
Top Partner Programs
USG Aggregated Agencies:
$6,326,674
Countries/Regions
Central Asia Region
2015 | $4,926,674 |
2017 | $1,400,000 |
U.S. Centers for Disease Control and Prevention:
$3,238,500
Countries/Regions
Central Asia Region
2013 | $3,238,500 |
U.S. Agency for International Development:
$2,538,500
Countries/Regions
Central Asia Region
2013 | $2,538,500 |